Stock Research: Granules India

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Granules India

BSE:532482 INE101D01020
71
  • Value
    39
  • Growth
    81
  • Safety
    Safety
    47
  • Combined
    61
  • Sentiment
    68
  • 360° View
    360° View
    71
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Granules India Limited is an India-based pharmaceutical manufacturing company. It operates in pharmaceutical products, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs), and finished dosages, and owns Senn Chemicals AG, a CDMO specializing in peptide development and manufacturing. The company sells its products in global markets, including India, the United States of America, Canada, Latin America, Europe, and Asia Pacific. In the last fiscal year, the company had a market cap of $1410 million, profits of $323 million, and revenue of $524 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 71 (better than 71% compared with alternatives), overall professional sentiment and financial characteristics for the stock Granules India are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Granules India. The consolidated Growth Rank has a good rank of 81, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 81% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 68, which means that professional investors are more optimistic about the stock than for 68% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 47, which means that the share price of Granules India is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 53% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 39, which means that the company has a financing structure that is riskier than those of 61% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
47 47 65 73
Growth
81 73 69 23
Safety
Safety
39 15 31 47
Sentiment
68 77 67 4
360° View
360° View
71 59 72 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
100 95 95 20
Opinions Change
50 72 11 50
Pro Holdings
n/a 70 67 42
Market Pulse
9 22 46 29
Sentiment
68 77 67 4
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
47 47 65 73
Growth
81 73 69 23
Safety Safety
39 15 31 47
Combined
61 33 63 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
70 62 86 74
Price vs. Earnings (P/E)
59 60 82 78
Price vs. Book (P/B)
53 53 73 67
Dividend Yield
14 12 10 36
Value
47 47 65 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
80 80 72 72
Profit Growth
64 69 32 8
Capital Growth
41 27 80 45
Stock Returns
71 79 55 27
Growth
81 73 69 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
31 30 32 36
Refinancing
42 36 46 58
Liquidity
44 32 48 55
Safety Safety
39 15 31 47

Similar Stocks

Discover high‑ranked alternatives to Granules India and broaden your portfolio horizons.

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Dr. Reddy's

BSE:500124
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

L&T Finance Holdings

BSE:533519
Country: India
Industry: Other Financial Services
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.